Crossmark

Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior

Crossref DOI link: https://doi.org/10.1186/s12951-018-0357-y

Published Online: 2018-03-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Santos, Catarina

Turiel, Suzy

Sousa Gomes, Pedro

Costa, Elísio

Santos-Silva, Alice

Quadros, Paulo

Duarte, José

Battistuzzo, Sílvia

Fernandes, Maria Helena https://orcid.org/0000-0001-9391-9574
Funding

Funding for this research was provided by:

FEDER (POCI/01/0145/FEDER/007265)

Fundação para a Ciência e a Tecnologia (PT2020 UID/QUI/50006/2013, CQE (UID/QUI/00100/2013)

CAPES (MEC/MCTI/CAPES/CNPq/FAPs Nº 71/2013)
License Information

Text and Data Mining valid from 2018-03-22
More Information

Article History

Received: 12 October 2017

Accepted: 19 March 2018

First Online: 22 March 2018